HIV-1 and its transmembrane protein gp41 bind to different Candida species modulating adhesion

FEMS Immunology and Medical Microbiology

Volumn 37, Issue 1, 2003, Pages 77-83

  Gruber, Andreas ^a,e   Lell, Claudia P ^a   Spruth, Martin ^a   Lass Flörl, Cornelia ^a   Speth, Cornelia ^a   Stoiber, Heribert ^a   Hube, Bernhard ^b   Coleman, David ^c   Polonelli, Luciano ^d   Dierich, Manfred P ^a   Würzner, Reinhard ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b ROBERT KOCH INSTITUTE   (Germany)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d UNIVERSITY OF PARMA   (Italy)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adhesion; Candida; Complement; Human immunodeficiency virus; Secreted aspartic proteinase

Indexed keywords

GLYCOPROTEIN GP 41; MEMBRANE PROTEIN; PROTEINASE; TOXIN;

ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CONTROLLED STUDY; DELETION MUTANT; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE ADHERENCE; PRIORITY JOURNAL; PROTEIN BINDING; SACCHAROMYCES CEREVISIAE; T LYMPHOCYTE; VIRULENCE; WILD TYPE;

EID: 0037722830     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00110-X     Document Type: Article

References (42)

1. Klein R.S., Harris C.A., Small C.B., Moll B., Lesser M., Friedland G.H. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. New Engl. J. Med. 311:1984;354-358.
2. Ponton J., Rüchel R., Clemons K.V., Coleman D.C., Grillot R., Guarro J., Aldebert D., Ambroise-Thomas P., Cano J., Carrillo-Munoz A.J., Gene J., Pinel C., Stevens D.A., Sullivan D.J. Emerging pathogens. Med. Mycol. 38:2000;225-236.
3. Coleman D.C., Sullivan D.J., Bennett D.E., Moran G.P., Barry H.J., Shanley D.B. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS. 11:1997;557-567.
4. Quinti I., Palma C., Guerra E.C., Gomez M.J., Mezzaroma I., Aiuti F., Cassone A. Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Clin. Exp. Immunol. 85:1991;485-492.
5. Cantorna M.T., Balish E. Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infect. Immun. 59:1991;2447-2455.
6. Tylenda C.A., Larsen J., Yeh C.K., Lane H.C., Fox P.C. High levels of oral yeasts in early HIV-1 infection. J. Oral Pathol. Med. 18:1989;520-524.
7. Gottfredsson M., Cox G.M., Indridason O.S., de Almeida G.M., Heald A.E., Perfect J.R. Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization. J. Infect. Dis. 180:1999;534-537.
8. Imbert-Bernard C., Valentin A., Reynes J., Mallie M., Bastide J.M. Relationship between fluconazole sensitivity of Candida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count. Eur. J. Clin. Microbiol. Infect. Dis. 13:1994;711-716.
9. Sweet S.P., Cookson S., Challacombe S.J. Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells. J. Med. Microbiol. 43:1995;452-457.
10. Schmid J., Odds F.C., Wiselka M.J., Nicholson K.G., Soll D.R. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J. Clin. Microbiol. 30:1992;935-941.
11. Ollert M.W., Wende C., Gorlich M., McMullan-Vogel C.G., Borg-von Zepelin M., Vogel C.W., Korting H.C. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J. Clin. Microbiol. 33:1995;2543-2549.
12. Würzner R., Gruber A., Stoiber H., Spruth M., Chen Y.H., Lukasser-Vogl E., Schwendinger M.G., Dierich M.P. Human immunodeficiency virus type 1 gp41 binds to Candida albicans via complement C3-like regions. J. Infect. Dis. 176:1997;492-498.
13. Stoiber H., Ebenbichler C., Schneider R., Janatova J., Dierich M.P. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS. 9:1995;19-26.
14. Stoiber H., Schneider R., Janatova J., Dierich M.P. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology. 193:1995;98-113.
15. Heidenreich F., Dierich M.P. Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b. Infect. Immun. 50:1985;598-600.
16. Gruber A., Lukasser-Vogl E., Borg-von Zepelin M., Dierich M.P., Würzner R. Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro. J. Infect. Dis. 177:1998;1057-1063.
17. Macdonald F., Odds F.C. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J. Gen. Microbiol. 129:1983;431-438.
18. De Bernardis F., Arancia S., Morelli L., Hube B., Sanglard D., Schafer W., Cassone A. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J. Infect. Dis. 179:1999;201-208.
19. De Bernardis F., Chiani P., Ciccozzi M., Pellegrini G., Ceddia T., D'Offizzi G., Quinti I., Sullivan P.A., Cassone A. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect. Immun. 64:1996;466-471.
20. Wu T., Samaranayake L.P., Cao B.Y., Wang J. In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents. J. Med. Microbiol. 44:1996;311-316.
21. Hube B., Naglik J. Candida albicans proteinases: resolving the mystery of a gene family. Microbiology. 147:2001;1997-2005.
22. Xia Y., Borland G., Huang J., Mizukami I.F., Petty H.R., Todd R.F. III, Ross G.D. Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. J. Immunol. 169:2002;6417-6426.
23. Gale C.A., Bendel C.M., McClellan M., Hauser M., Becker J.M., Berman J., Hostetter M.K. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science. 279:1998;1355-1358.
24. Borg M., Rüchel R. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect. Immun. 56:1988;626-631.
25. Hube B., Sanglard D., Odds F.C., Hess D., Monod M., Schafer W., Brown A.J., Gow N.A. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect. Immun. 65:1997;3529-3538.
26. Gruber A., Speth C., Lukasser-Vogl E., Zangerle R., Borg-von Zepelin M., Dierich M.P., Würzner R. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro. Immunopharmacology. 41:1999;227-234.
27. Buchacher A., Predl R., Strutzenberger K., Steinfellner W., Trkola A., Purtscher M., Gruber G., Tauer C., Steindl F., Jungbauer A., Katinger H. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res. Hum. Retroviruses. 10:1994;359-369.
28. Stiegler G., Armbruster C., Vcelar B., Stoiber H., Kunert R., Michael N.L., Jagodzinski L., Ammann C., Jäger W., Jacobson J., Vetter N., Katinger H. Antiviral effects of the human neutralizing antibodies 2F5 and 2G12 in humans infected with HIV-1. AIDS. 16:2002;2019-2025.
29. Würzner R., Langgartner M., Spötl L., Eder A., Bujdakova H., Schröppel K., Dierich M.P. Temperature-dependent surface expression of the beta-2-integrin analogue of Candida albicans and its role in adhesion to the human endothelium. Exp. Clin. Immunogenet. 13:1996;161-172.
30. Sullivan D., Coleman D. Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36:1998;329-334.
31. Frank I., Stoiber H., Godar S., Stockinger H., Steindl F., Katinger H.W., Dierich M.P. Acquisition of host cell-surface-derived molecules by HIV-1. AIDS. 10:1996;1611-1620.
32. Tremblay M.J., Fortin J.F., Cantin R. The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today. 19:1998;346-351.
33. Bendel C.M., Hostetter M.K. Distinct mechanisms of epithelial adhesion for Candida albicans and Candida tropicalis. Identification of the participating ligands and development of inhibitory peptides. J. Clin. Invest. 92:1993;1840-1849.
34. Schwab U., Milatovic D., Braveny I. Increased adherence of Candida albicans to buccal epithelial cells from patients with AIDS. Eur. J. Clin. Microbiol. Infect. Dis. 16:1997;848-851.
35. Pereiro M.J., Losada A., Toribio J. Adherence of Candida albicans strains isolated from AIDS patients. Comparison with pathogenic yeasts isolated from patients without HIV infection. Br. J. Dermatol. 137:1997;76-80.
36. Tsang C.S., Samaranayake L.P. Factors affecting the adherence of Candida albicans to human buccal epithelial cells in human immunodeficiency virus infection. Br. J. Dermatol. 141:1999;852-858.
37. Speth C., Pichler I., Stöckl G., Mair M., Dierich M.P. Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection. Immunobiology. 199:1998;152-162.
38. De Bernardis F., Agatensi L., Ross I.K., Emerson G.W., Lorenzini R., Sullivan P.A., Cassone A. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J. Infect. Dis. 161:1990;1276-1283.
39. Ollert M.W., Sohnchen R., Korting H.C., Ollert U., Brautigam S., Brautigam W. Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect. Immun. 61:1993;4560-4568.
40. Watts H.J., Cheah F.S., Hube B., Sanglard D., Gow N.A. Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. FEMS Microbiol. Lett. 159:1998;129-135.
41. de Repentigny L., Aumont F., Bernard K., Belhumeur P. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect. Immun. 68:2000;3172-3179.
42. Cassone A., Conti S., De Bernardis F., Polonelli L. Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature? Immunol. Today. 18:1997;164-169.